Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$26.1K 59
2024
Q4
$26.1K Hold
100
0.02% 89
2024
Q3
$32.2K Sell
100
-19
-16% -$6.21K 0.03% 89
2024
Q2
$37.2K Hold
119
0.04% 82
2024
Q1
$33.8K Buy
119
+15
+14% +$4.39K 0.04% 73
2023
Q4
$30K Buy
104
+100
+2,500% +$27.2K 0.04% 76
2023
Q3
$1.03K Hold
4
﹤0.01% 219
2023
Q2
$889 Hold
4
﹤0.01% 227
2023
Q1
$967 Hold
4
﹤0.01% 227
2022
Q4
$1.05K Hold
4
﹤0.01% 231
2022
Q3
$1K Buy
+4
New +$970 ﹤0.01% 208

Other funds holding AMGN

Delos Wealth Advisors's AMGN Position: Q1 2025 in Review

Delos Wealth Advisors sold out of Amgen (AMGN) in Q1 2025, closing a stake of 100 shares — an estimated $26.1K sold.

Delos Wealth Advisors first reported a position in AMGN in Q3 2022 and held it in 10 quarters. The position peaked at $37.2K in Q2 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Delos Wealth Advisors reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Delos Wealth Advisors sold 100 Amgen shares in Q1 2025, an estimated $26.1K.
  • Delos Wealth Advisors first reported a position in Amgen in Q3 2022 and held it in 10 quarters.
  • Delos Wealth Advisors's Amgen position peaked at $37.2K in Q2 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Delos Wealth Advisors's 13F filing for Q1 2025, filed 13 May 2025.